blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0251459

EP0251459 - Controlled release pharmaceutical composition [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.05.1993
Database last updated on 20.05.2024
Most recent event   Tooltip13.05.1993No opposition filed within time limitpublished on 30.06.1993 [1993/26]
Applicant(s)For all designated states
Euroceltique S.A.
122 Boulevard de la Petrusse
Luxembourg / LU
[1988/01]
Inventor(s)01 / Elger, Gordon Anthony
99 Greenfields Earith
Huntingdon Cambridge / GB
02 / Leslie, Stewart Thomas
4 Babraham Road
Cambridge / GB
03 / Malkowska, Sadra Therese Antoinette
14 Abrahams Close
Landbeach Cambridge / GB
04 / Miller, Ronald Brown
Bruderholzallee, 191
CH-4059 Basel / CH
05 / Neale, Philip John
28 London Road
Harston Cambridge / GB
[1988/01]
Representative(s)Lamb, John Baxter, et al
Marks & Clerk 90 Long Acre
London WC2E 9RA / GB
[N/P]
Former [1990/04]Lamb, John Baxter, et al
MARKS & CLERK, 57-60 Lincoln's Inn Fields
London WC2A 3LS / GB
Former [1988/01]James, Stephen Richard, Dr.
Napp Research Centre Cambridge Science Park Milton Road
Cambridge CB2 2RA / GB
Application number, filing date87304189.112.05.1987
[1988/01]
Priority number, dateGB1986001368805.06.1986         Original published format: GB 8613688
[1988/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0251459
Date:07.01.1988
Language:EN
[1988/01]
Type: A3 Search report 
No.:EP0251459
Date:25.05.1988
Language:EN
[1988/21]
Type: B1 Patent specification 
No.:EP0251459
Date:08.07.1992
Language:EN
[1992/28]
Search report(s)(Supplementary) European search report - dispatched on:EP05.04.1988
ClassificationIPC:A61K9/22
[1988/01]
CPC:
A61K9/205 (EP,US); A61K9/2013 (EP,US); A61K9/2031 (EP,US)
Designated contracting statesDE,   FR,   GB,   IT [1988/01]
TitleGerman:Arzneimittel mit gesteuerter Freisetzung[1988/01]
English:Controlled release pharmaceutical composition[1988/01]
French:Composition pharmaceutique à libération contrôlée[1988/01]
Examination procedure19.08.1988Examination requested  [1988/43]
23.08.1990Despatch of a communication from the examining division (Time limit: M06)
25.02.1991Reply to a communication from the examining division
30.04.1991Despatch of a communication from the examining division (Time limit: M02)
21.06.1991Reply to a communication from the examining division
04.11.1991Despatch of communication of intention to grant (Approval: Yes)
19.12.1991Communication of intention to grant the patent
24.03.1992Fee for grant paid
24.03.1992Fee for publishing/printing paid
Opposition(s)09.04.1993No opposition filed within time limit [1993/26]
Fees paidRenewal fee
18.05.1989Renewal fee patent year 03
10.04.1990Renewal fee patent year 04
15.04.1991Renewal fee patent year 05
09.04.1992Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]FR2140217  (MUNDIPHARMA AG);
 [A]US3965256  (LESLIE STEWART THOMAS);
 [A]EP0032004  (EURO CELTIQUE SA [LU]);
 [X]FR2496460  (CHINOIN GYOGYSZER ES VEGYESZET [HU]);
 [YP]EP0205282  (EURO CELTIQUE SA [LU])
 [YP]  - CHEMICAL ABSTRACTS, vol. 106, 1987, page 270, abstract no. 9287p, Columbus, Ohio, US; A.E. ABOUTALEB et al.: "Studies of cyclodextrin inclusion complexes: I. Inclusion complexes between alpha- and beta-cyclodextrins and chloramphenicol in aqueous solutions", & DRUG DEV. IND. PHARM. 1986, 12(11-13), 2259-79
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.